443 related articles for article (PubMed ID: 16809320)
21. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
[TBL] [Abstract][Full Text] [Related]
22. CD1 antigen presentation and infectious disease.
Dascher CC; Brenner MB
Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
[TBL] [Abstract][Full Text] [Related]
23. Invariant NKT cells amplify the innate immune response to lipopolysaccharide.
Nagarajan NA; Kronenberg M
J Immunol; 2007 Mar; 178(5):2706-13. PubMed ID: 17312112
[TBL] [Abstract][Full Text] [Related]
24. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.
Zeng D; Liu Y; Sidobre S; Kronenberg M; Strober S
J Clin Invest; 2003 Oct; 112(8):1211-22. PubMed ID: 14561706
[TBL] [Abstract][Full Text] [Related]
25. Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection.
Zhao L; Gao X; Peng Y; Joyee AG; Bai H; Wang S; Yang J; Zhao W; Yang X
Immunology; 2011 Oct; 134(2):172-84. PubMed ID: 21896012
[TBL] [Abstract][Full Text] [Related]
26. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
27. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.
Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG
J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704
[TBL] [Abstract][Full Text] [Related]
28. The Variable Genomic NK Cell Receptor Locus Is a Key Determinant of CD4+ T Cell Responses During Viral Infection.
Raynor J; Lin A; Hummel SA; Lampe K; Jordan M; Hoebe K; Hildeman DA
Front Immunol; 2020; 11():197. PubMed ID: 32153566
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.
Brigl M; Bry L; Kent SC; Gumperz JE; Brenner MB
Nat Immunol; 2003 Dec; 4(12):1230-7. PubMed ID: 14578883
[TBL] [Abstract][Full Text] [Related]
30. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
Kim JH; Choi EY; Chung DH
J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
[TBL] [Abstract][Full Text] [Related]
31. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
[TBL] [Abstract][Full Text] [Related]
32. Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies.
Neal ZC; Splitter GA
J Virol; 1998 Oct; 72(10):8052-60. PubMed ID: 9733845
[TBL] [Abstract][Full Text] [Related]
33. Sex hormone modulation of interferon (IFN) alpha/beta and gamma production by mouse spleen cell subsets following picornavirus infection.
Ishikawa R; Bigley NJ
Viral Immunol; 1990; 3(3):225-36. PubMed ID: 2175195
[TBL] [Abstract][Full Text] [Related]
34. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation.
Sköld M; Xiong X; Illarionov PA; Besra GS; Behar SM
J Immunol; 2005 Sep; 175(6):3584-93. PubMed ID: 16148102
[TBL] [Abstract][Full Text] [Related]
35. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo.
Renukaradhya GJ; Sriram V; Du W; Gervay-Hague J; Van Kaer L; Brutkiewicz RR
Int J Cancer; 2006 Jun; 118(12):3045-53. PubMed ID: 16395717
[TBL] [Abstract][Full Text] [Related]
37. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.
Hansen DS; Siomos MA; De Koning-Ward T; Buckingham L; Crabb BS; Schofield L
Eur J Immunol; 2003 Sep; 33(9):2588-98. PubMed ID: 12938235
[TBL] [Abstract][Full Text] [Related]
38. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
[TBL] [Abstract][Full Text] [Related]
39. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
Huber S; Song WC; Sartini D
Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
[TBL] [Abstract][Full Text] [Related]
40. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
